Steve O'Loughlin

2021

In 2021, Steve O'Loughlin earned a total compensation of $967K as Chief Financial Officer at Actinium Pharmaceuticals, a 18% increase compared to previous year.

Compensation breakdown

Bonus$150,000
Option Awards$447,034
Salary$370,000
Total$967,034

O'Loughlin received $447K in option awards, accounting for 46% of the total pay in 2021.

O'Loughlin also received $150K in bonus and $370K in salary.

Rankings

In 2021, Steve O'Loughlin's compensation ranked 8,883rd out of 12,406 executives tracked by ExecPay. In other words, O'Loughlin earned more than 28.4% of executives.

ClassificationRankingPercentile
All
8,883
out of 12,406
28th
Division
Manufacturing
3,931
out of 5,492
28th
Major group
Chemicals And Allied Products
1,730
out of 2,368
27th
Industry group
Drugs
1,539
out of 2,089
26th
Industry
Pharmaceutical Preparations
1,145
out of 1,536
26th
Source: SEC filing on November 21, 2022.

O'Loughlin's colleagues

We found three more compensation records of executives who worked with Steve O'Loughlin at Actinium Pharmaceuticals in 2021.

2021

Sandesh Seth

Actinium Pharmaceuticals

Chief Executive Officer

2021

Mark Berger

Actinium Pharmaceuticals

Chief Medical Officer

2021

Dale Ludwig

Actinium Pharmaceuticals

Former Chief Scientific and Technology Officer

News

You may also like